Senior insider sale
Chief Executive Officer at CENTESSA PHARMACEUTICALS PLC — senior position signals high conviction
$60.75M
2.50M shares
What this filing means
SAHA SAURABH plans to sell 2.50M shares of CENTESSA PHARMACEUTICALS PLC valued at approximately $60.75M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 1/2/2026ACC: 0001969223-26-000012
DirectorOfficer· Chief Executive Officer
Since May 2021
2.50M
Shares to sell
$60.75M
Approx. market value
2.50M
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Stock Option Exercise
Cash
1/2/2025
2.50MTotal acquired2.50M
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/2/2025 | Stock Option Exercise Cash | 2.50M | — |
| Total | 2.50M | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
2.50M
Market value
$60.75M
1/2/2026
Total
Units
2.50M
Value
$60.75M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
1/2/2026 | 2.50M | $60.75M | NASDAQ | Planned |
| Total | 2.50M | $60.75M | ||